AstraZeneca buying drug developer in £30bn deal
Published
Pharmaceutical giant AstraZeneca is to buy US drug developer Alexion in a deal worth almost £30 billion.
Full ArticlePublished
Pharmaceutical giant AstraZeneca is to buy US drug developer Alexion in a deal worth almost £30 billion.
Full ArticleNEW YORK (AP) — Stocks that moved heavily or traded substantially Monday:
Alexion Pharmaceuticals Inc., up $35.33 to..